FIELD: medicine, obstetrics, gynecology.
SUBSTANCE: female patients at pregravidic stage should be prescribed with Vobenzyme preparation at the dosage of 5 lzg thrice daily during the next 2 mo; basic therapy should be continued with this preparation at the background of pregnancy at maintaining dosage of 3 lzg thrice daily at its further abolition 2 wk before supposed delivery. The present innovation is very useful for both prophylaxis and therapy in case of thrombotic complications during pregnancy in women at customary failed pregnancy induced by antiphospholipid syndrome due to correcting coagulopathic disorders with the help of systemic enzymotherapy, Vobenzyme preparation, in particular.
EFFECT: higher efficiency of therapy.
3 ex
